Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

par Colhoun, H. M.
Publié 2009

Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks?

par Cleland, S. J., Fisher, B. M., Colhoun, H. M., Sattar, N., Petrie, J. R.
Publié 2013

Investigation of known estimated glomerular filtration rate loci in patients with Type 2 diabetes

par Deshmukh, H A, Palmer, C N A, Morris, A D, Colhoun, H M
Publié 2013

A genome‐wide association study suggests that MAPK14 is associated with diabetic foot ulcers

par Meng, W., Veluchamy, A., Hébert, H.L., Campbell, A., Colhoun, H.M., Palmer, C.N.A.
Publié dans Br J Dermatol (2017)

Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis

par McGurnaghan, S., Blackbourn, L. A. K., Mocevic, E., Haagen Panton, U., McCrimmon, R. J., Sattar, N., Wild, S., Colhoun, H. M.
Publié dans Diabet Med (2018)

Human immunodeficiency virus infection in Northern Ireland 1980-1989.

par Maw, R. D., Connolly, J. H., Mayne, E. E., McClelland, W., Dinsmore, W. W., Horner, T., Boyd, J. S., Colhoun, H. M., Doherty, L., Simpson, D. M.
Publié 1991

Type 2 diabetes, socioeconomic status and risk of cancer in Scotland 2001-2007

par Walker, J. J., Brewster, D. H., Colhoun, H. M., Fischbacher, C. M., Leese, G. P., Lindsay, R. S., McKnight, J. A., Philip, S., Sattar, N., Stockton, D. L., Wild, S. H.
Publié 2013

A genome‐wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain

par Meng, W., Deshmukh, H.A., van Zuydam, N.R., Liu, Y., Donnelly, L.A., Zhou, K., Morris, A.D., Colhoun, H.M., Palmer, C.N.A., Smith, B.H.
Publié dans Eur J Pain (2015)

Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland

par Looker, H. C., Nyangoma, S. O., Cromie, D., Olson, J. A., Leese, G. P., Black, M., Doig, J., Lee, N., Lindsay, R. S., McKnight, J. A., Morris, A. D., Philip, S., Sattar, N., Wild, S. H., Colhoun, H. M.
Publié 2012

Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme

par Looker, H C, Nyangoma, S O, Cromie, D T, Olson, J A, Leese, G P, Black, M W, Doig, J, Lee, N, Lindsay, R S, McKnight, J A, Morris, A D, Pearson, D W M, Philip, S, Wild, S H, Colhoun, H M
Publié 2014

End-stage renal disease and survival in people with diabetes: a national database linkage study

par Bell, S., Fletcher, E.H., Brady, I., Looker, H.C., Levin, D., Joss, N., Traynor, J.P., Metcalfe, W., Conway, B., Livingstone, S., Leese, G., Philip, S., Wild, S., Halbesma, N., Sattar, N., Lindsay, R.S., McKnight, J., Pearson, D., Colhoun, H.M.
Publié dans QJM (2015)

The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control

par Casanova, F., Adingupu, D. D., Adams, F., Gooding, K. M., Looker, H. C., Aizawa, K., Dove, F., Elyas, S., Belch, J. J. F., Gates, P. E., Littleford, R. C., Gilchrist, M., Colhoun, H. M., Shore, A. C., Khan, F., Strain, W. D.
Publié dans Cardiovasc Diabetol (2017)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

par Colhoun, H. M., Livingstone, S. J., Looker, H. C., Morris, A. D., Wild, S. H., Lindsay, R. S., Reed, C., Donnan, P. T., Guthrie, B., Leese, G. P., McKnight, J., Pearson, D. W. M., Pearson, E., Petrie, J. R., Philip, S., Sattar, N., Sullivan, F. M., McKeigue, P.
Publié 2012

Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme

par Looker, H. C., Nyangoma, S. O., Cromie, D. T., Olson, J. A., Leese, G. P., Philip, S., Black, M. W., Doig, J., Lee, N., Briggs, A., Hothersall, E. J., Morris, A. D., Lindsay, R. S., McKnight, J. A., Pearson, D. W. M., Sattar, N. A., Wild, S. H., McKeigue, P., Colhoun, H. M.
Publié 2013